A Phase II Sequential Dose-escalation Study Evaluating the Safety and Feasibility of Allogenlc Umbillcal Cord Derived Mesenchymal Stromal Cells for the Treatment of Adults w/ Treatment Refractory Lupus

Project: Research project

Project Details

Description

Report on eligible participant enrollment at weekly intervals.
Provide data to the Data Coordinating Center at regular intervals.
Provide financial expenditure invoices/reports on a monthly basis and at other times when requested.
Provide scientific progress reports as required by the prime grantee and the sponsor.
StatusActive
Effective start/end date10/1/209/30/21

Funding

  • Medical University of South Carolina (A00-3635-S021)
  • Lupus Foundation of America, Inc. (A00-3635-S021)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.